← Leaderboards
John Beutler
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogSourceCollaborationsSamplingCellsPlantsCollectionUniversitiesStructureSeriesMolecular TargetNatural ProductsPathway InteractionsBiological TestingLibrariesBasePharmacologic SubstanceAnimal ModelCentral Nervous System NeoplasmsProgramsCancer Cell GrowthMalignant NeoplasmsMaterial Transfer AgreementIn Vivo Model
Grant awards (28)
Development of Natural Product Leads as Anticancer Therapeutics$981,960
ZIA · FY2025 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$981,960
ZIA · FY2025 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$902,657
ZIA · FY2024 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$902,657
ZIA · FY2024 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$798,286
ZIA · FY2023 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$798,286
ZIA · FY2023 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$602,680
ZIA · FY2022 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$602,680
ZIA · FY2022 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$589,144
ZIA · FY2021 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$589,144
ZIA · FY2021 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$687,723
ZIA · FY2020 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$687,723
ZIA · FY2020 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$630,232
ZIA · FY2019 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$630,232
ZIA · FY2019 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$466,064
ZIA · FY2018 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$466,064
ZIA · FY2018 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$435,393
ZIA · FY2017 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$435,393
ZIA · FY2017 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$408,562
ZIA · FY2016 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$408,562
ZIA · FY2016 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$263,551
ZIA · FY2015 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$263,551
ZIA · FY2015 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$341,671
ZIA · FY2014 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$341,671
ZIA · FY2014 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$313,765
ZIA · FY2013 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$313,765
ZIA · FY2013 · CA · contact PI
Development of Natural Product Leads as Anticancer Therapeutics$330,078
ZIA · FY2012 · CA · contact PI
Building Libraries with Chemical Diversity for Screening$330,078
ZIA · FY2012 · CA · contact PI